3SBio Inc. (OTCMKTS:TRSBF) Sees Significant Increase in Short Interest

3SBio Inc. (OTCMKTS:TRSBF) was the recipient of a significant growth in short interest in the month of July. As of July 15th, there was short interest totaling 14,802,882 shares, a growth of 142.1% from the June 30th total of 6,115,388 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is presently ∞ days.

3SBio Price Performance

TRSBF stock opened at $2.15 on Wednesday. The business’s 50-day moving average price is $2.26 and its 200-day moving average price is $2.66. 3SBio has a twelve month low of $2.00 and a twelve month high of $4.74.

3SBio Company Profile

3SBio Inc (OTCMKTS: TRSBF) is a China-based biopharmaceutical company focused on the research, development, manufacturing and commercialization of protein-based therapeutics and chemical drugs. Established in 1999 and headquartered in Shenyang, Liaoning Province, the company has built an integrated platform that encompasses in-house R&D capabilities, clinical development, commercial production and a nationwide sales network.

The company’s product portfolio features a range of hematopoietic growth factors such as recombinant human granulocyte colony-stimulating factor (rhG-CSF) and recombinant human erythropoietin (rhEPO), insulin and insulin analogs, hemostasis agents and monoclonal antibodies.